ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Innovit Announces GDSN.cloud Solution

By: PRLog

Cost-Effective and Easy-to-use system Accelerates the Ability for Healthcare Manufacturers to Share Validated Product Data!

SAN FRANCISCO - June 8, 2022 - PRLog -- Innovit, the Product Information Management (PIM) specialists who enable Healthcare Providers and Medical Products Suppliers to deliver trusted product data for supply chain management and clinical performance optimization, today announced their GDSN.cloud solution enabling healthcare manufacturers to easily share accurate & validated product data to the GDSN.

This out-of-the-box solution improves master data consistency and streamlines data governance processes.  Healthcare suppliers can now leverage one solution to aggregate, validate, convert, and publish your data to all target markets.  Suppliers can also add-on a subscription to the world's leading Healthcare data pool from Innovit partner – atrify!

GDSN.cloud simplifies the aggregation of product master data from all source systems by converting this internal data into the GDSN compliant formats required for publication to GPOs, hospitals, and regulatory databases (e.g., US FDA, China NMPA, Vizient, NHS).  This pre-packaged solution includes GS1 attributes, data validations and valid code lists.

GDSN.cloud is a low-cost solution with the goal of making master data management just a little easier with complete visibility to the product data synchronization process.  Healthcare manufacturers can easily review their product data against the latest GS1 validations and attributes to ensure data compliance.

"We're thrilled to announce our GDSN.cloud system which simplifies product data management, approval and publications," said Bang Chau, VP of Strategic Business Development at Innovit.  "As global data syndication use cases continue to evolve, medical device manufacturers can leverage one solution to simplify the mass distribution and syndication of trustworthy product master data.  Further, Innovit's preconfigured workflows help users enrich, validate, approve and publish product catalogs to trading partners via GDSN data pools – right out of the box!"

Today, medical device manufacturers can leverage a single full-service approach to managing and exchanging their validated medical device data with hospitals and regulators around the globe.

Innovit will be exhibiting and meeting with industry members and customers in person today at the GS1 Connect Conference in San Diego, June 7-9 in booth #108.

Companies that sign-up before June 30th get three months free. Learn More

About Innovit
Innovit simplifies the process of managing, validating and exchanging trusted product data to enable regulatory compliance, reduce procurement spend and ensure patient safety.
With over 22 years of experience in master data management and regulatory compliance, Innovit enables companies to easily share validated product data at a much lower cost. We have a proven track record in delivering 'globally scalable' product data management systems that enable Medical Device suppliers and Healthcare Providers to meet compliance deadlines, promote patient & consumer safety, while increasing supply chain efficiencies.

Operating since 2000, Innovit is based in San Francisco with offices in London, Dusseldorf and Sydney, serving customers across the Healthcare and Life Science supply chains, such as Mayo Clinic, South Australia Health, Southern Cross Hospitals, 3M, Abbott, Arthrex, Ascensia Diabetes, B. Braun, Bio-Rad, Molnlycke, ThermoFisher, Zimmer Biomet.

Contact
Ashley E Howell
***@gmail.com

Photos: (Click photo to enlarge)

Innovit Logo

Read Full Story - Innovit Announces GDSN.cloud Solution | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.